Skip to main content

2018 CCIA Projects

A Platform Trial Design to Accelerate Translational Therapies in a Canine Disease Model of ALS

University of Missouri

Principal Investigator: Joan Ripley Coates, D.V.M., M.S., and Sarah A. Moore, D.V.M. 
Grant Number: 1-R21TR002277-01A1 
Collaborating Institutions: The Ohio State University, Tufts University, North Carolina State University, Voyager Therapeutics

Learn more about this project in the NIH RePORTER.

Accelerate Cellular Immunotherapy Development for Treatment of Life-Threatening Childhood Disorders

Seattle Children’s Hospital

Principal Investigator: Julie R. Park, M.D., and Bonnie W. Ramsey, M.D. 
Grant Number: 1-U01TR002487-01 
Collaborating Institutions: Children’s National Health System, UCSF Benioff Children’s Hospital, Children’s Hospital Los Angeles, University of Colorado Denver, Fred Hutchinson Cancer Research Center

Learn more about this project in the NIH RePORTER.

Project Website: Consortium for Pediatric Cellular Immunotherapy 

Effects of apoE-Enhancing Compounds on Alzheimer’s Disease Phenotypes In Vivo

Columbia University

Principal Investigators: Tae-Wan Kim, Ph.D., and John R. Cirrito, Ph.D. 
Grant Number: 1-R21TR002029-01A1 
Collaborating Institution: Washington University in St. Louis

Learn more about this project in the NIH RePORTER.

Harnessing Human Brain and Liver Microphysiological Systems for Testing Therapeutics for Metastatic Melanoma

Vanderbilt University

Principal Investigator: John Peter Wikswo, Ph.D., M.S., William L. Murphy, Ph.D., M.S., and D. Lansing Taylor, Ph.D. 
Grant Number: 1-U01TR002383-01 
Collaborating Institutions: University of Wisconsin–Madison, University of Pittsburgh School of Medicine, AstraZeneca

Learn more about this project in the NIH RePORTER.

Project Website: Dr. Lans Taylor PI on Multi-PI U01 grant to study “Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma”

Harnessing the Power of CTSA-CDRN Data Networks: Using Social Determinants of Health, Frailty and Functional Status to Identify At-Risk Patients and Improve Risk Adjustment

University of Texas Health Science Center at San Antonio

Principal Investigator: Paula K. Shireman, M.D., M.S. 
Grant Number: 1-U01TR002393-01 
Collaborating Institutions: University of Texas at Austin, University of Texas Health Science Center at Houston, University of Pittsburgh

Learn more about this project in the NIH RePORTER.

Project Website: Harnessing the Power of CTSA-CDRN Data Networks: Using Social Determinants of Health, Frailty, and Functional Status to Identify At-Risk Patients and Improve Risk Adjustment

Impact of Breast Milk on Infant Gut Microbiome

University of Rochester

Principal Investigator: Kirsi Järvinen-Seppo, M.D., Ph.D., and R. John Looney, M.D. 
Grant Number: 1-R21TR002516-01 
Collaborating Institutions: University of California, San Diego, Icahn School of Medicine at Mount Sinai

Learn more about this project in the NIH RePORTER.

Increasing Access to Clinical Microbiome Specimens via a Living µBiome Bank

Medical University of South Carolina

Principal Investigator: Alexander V. Alekseyenko, Ph.D. 
Grant Number: 1-R21TR002513-01 
Collaborating Institutions: University of Iowa, The George Washington University

Learn more about this project in the NIH RePORTER.

Project Website: Program for Human Microbiome Research

Peer-based Retention Of people who Use Drugs in Rural Research (PROUD-R2)

Oregon Health & Science University

Principal Investigator: Philip Todd Korthuis, M.D., M.P.H., and April Marie Young, Ph.D., M.P.H. 
Grant Number: 1-U01TR002631-01 
Collaborating Institutions: University of Kentucky Research Foundation, Emory University, University of North Carolina at Chapel Hill, The Ohio State University

Learn more about this project in the NIH RePORTER.

Project Website: PROUD-R2: The Peer-Based Retention of People who Use Drugs in Rural Research

Precision Medicine in the Diagnosis of Genetic Disorders in Neonates

Tufts Medical Center

Principal Investigator: Jonathan M. Davis, M.D., and Jill Lamanna Maron, M.D., M.P.H. 
Grant Number: 1-U01TR002271-01 
Collaborating Institutions: Rady Children’s Institute for Genomic Medicine, University of North Carolina at Chapel Hill, Columbia University, Icahn School of Medicine at Mount Sinai, UPMC Children’s Hospital of Pittsburgh, University of Michigan

Learn more about this project in the NIH RePORTER.

Project Website: Researchers receive NIH award to integrate genomic sequencing into neonatal diagnosis and care

TCR and BCR Deep Sequencing to Distinguish Autoimmune Recurrence from Allograft Rejection

Columbia University Health Sciences

Principal Investigator: Megan Sykes, M.D. 
Grant Number: 1-R21TR002279-01 
Collaborating Institution: University of Pennsylvania

Learn more about this project in the NIH RePORTER.

TEAMSS – Transforming Expanded Access to Maximize Support & Study

University of Michigan at Ann Arbor

Principal Investigator: George Alexander Mashour, M.D., and Kevin J. Weatherwax 
Grant Number: 1-U01TR002488-01 
Collaborating Institutions: University of Rochester, University of Texas Southwestern Medical Center, Duke University

Learn more about this project in the NIH RePORTER.

Project Website: TEAMSS Team Finds That Use of and Support for ‘Expanded Access’ is Widespread

Transforming Exercise Testing and Physical Activity Assessment in Children: New Approaches to Advance Clinical Translational Research in Child Health

University of California, Irvine

Principal Investigator: Dan M. Cooper, M.D., and Shlomit Radom-Aizik, Ph.D. 
Grant Number: 1-U01TR002004-01A1 
Collaborating Institutions: Ann & Robert H. Lurie Children’s Hospital of Chicago, Children’s Hospital Los Angeles

Learn more about this project in the NIH RePORTER.

Repurposing Misoprostol to Prevent Recurrence of Clostridium difficile Infection

Vanderbilt University Medical Center*

Principal Investigator: David M. Aronoff, M.D. 
Grant Number: 5U01TR002398-02 
Collaborating Institutions: Washington University in St. Louis; The University of North Carolina at Chapel Hill

Learn more about this project in the NIH RePORTER.

Project Website: Grant bolsters study of potential new therapy for C. diff infection

* Note: This U01 was funded by Drug Development Partnership Programs, Office of the Director, National Center for Advancing Translational Sciences.

Last updated on November 19, 2024